To better understand your feelings and expectations about immunotherapy
Primary Objective: 1\. To compare expectations of survival benefit from immunotherapy between advanced cancer patients with poor performance status (PS) and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of survival beyond 2 years. Secondary Objectives: 1. To compare expectations of therapeutic benefit of immunotherapy between advanced cancer patients with poor PS and their oncologists. We hypothesize that, compared to their oncologists, patients will have expectations for greater likelihood of cure, quality of life improvement, and lower likelihood of adverse events. 2. To qualitatively describe the priorities and preferences for information of advanced cancer patients with poor PS when considering immunotherapy treatment. 3. To evaluate the associations between discrepant expectations with patients' sociodemographic and clinical characteristics. 4. To compare patient and oncologist expectations with actual treatment outcomes and survival.
Study Type
OBSERVATIONAL
Enrollment
15
Participants will complete 5 questionnaires about any symptoms participants may be having, any anxiety and/or depression participants may be having, your preference in decision-making, and your expectations about your treatment. It should take about 30 minutes to complete all 5 questionnaires
The interview will last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom or FaceTime (based on your preference)
M D Anderson Cancer Center
Houston, Texas, United States
Discrepancy in expectation of survival for 2 years or more between the patient and oncologist
Time frame: through study completion; an average of 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.